1887

Abstract

SUMMARY

Infectious virus could not be recovered by disruption of human embryonic fibroblast cultures inoculated with cytomegalovirus and treated with cytosine-arabinoside (ara-C), either during treatment or 4 to 5 days after removing ara-C. However, when intact cells were used for infection, at least 1 in 70 cells was found harbouring virus. Examination by immunofluorescence revealed that 40 to 50% of the cells contained virus-specific antigens in the form of small granules diffusely distributed in the nuclei. The presence of infectious virus could be detected even in disrupted cells 4 to 5 days after removing ara-C; intracellular antigens of every kind were also found to develop. Experiments showed that the cultures continued to harbour latent infection indefinitely in the presence of ara-C. Cultures harbouring latent virus were susceptible to superinfection with cytomegalovirus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-18-2-143
1973-02-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/18/2/JV0180020143.html?itemId=/content/journal/jgv/10.1099/0022-1317-18-2-143&mimeType=html&fmt=ahah

References

  1. Craighead J. E., Hanshaw J. B., Carpenter C. B. 1967; Cytomegalo virus infection after renal allotrans-plantation. The Journal of the American Medical Association 201:725–728
    [Google Scholar]
  2. Diosi P., MoldovÁn E., Tomescu N. 1969; Latent cytomegalovirus infection in blood donors. British Medical Journal 4:660–662
    [Google Scholar]
  3. Duff R., Rapp F. 1971; Properties of hamster embryo fibroblast transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. Journal of Virology 8:469–477
    [Google Scholar]
  4. Géder L., Koller M., Gönczöl E., Jeney E., Gönczöl I. 1963; Isolation of herpes zoster virus strain. Acta microbiologica Academiae scientiarum hungaricae 10:155–161
    [Google Scholar]
  5. Gelderman A. H., Grimley P. M., Lunde M. N., Rabson A. S. 1968; Toxoplasma gondii and cytomegalo virus: mixed infection by a parasite and a virus. Science, New York 160:1130–1132
    [Google Scholar]
  6. Hinze H. C., Walker D. L. 1961; Variation of herpes simplex virus in persistently infected tissue cultures. Journal of Bacteriology 82:498–504
    [Google Scholar]
  7. Jensen F. C., Koprowski H. 1969; Absence of repressor in SV40-transformed cells. Virology 37:687–689
    [Google Scholar]
  8. Munk K., Runnebaum H. 1970; Virusinfectionen nach Organtransplantationen bei immunsuppressiver Therapie. Deutsche medizinische Wochenschrift 95:2252–2256
    [Google Scholar]
  9. O’neil F. J., Goldberg R. Y., Rapp F. 1972; Herpes simplex virus latency in cultured human cells following treatment with cytosine-arabinoside. The Journal of General Virology 14:189–197
    [Google Scholar]
  10. Perham T. G. M., Caul E. O., Coneway P. J., Mott M. G. 1971; Cytomegalovirus infection in blood donors - a prospective study. British Journal of Haematology 20:307–320
    [Google Scholar]
  11. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  12. Sauer G., Hahn E. C. 1970; The superinfection of abortively infected monkey kidney cells with SV40. Archiv fϋr die gesamte Virusforschung 30:267–270
    [Google Scholar]
  13. Seto D. S. Y., Carver D. H. 1969; Interaction between cytomegalovirus and Newcastle disease virus as mediated by intrinsic interference. Journal of Virology 4:12–14
    [Google Scholar]
  14. Szanto J. 1963; Course of persistent infection of HeLa and Detroit 6 cells with herpes simplex virus. Acta virologica 7:385–389
    [Google Scholar]
  15. Váczi L., Gönczöl E. 1972; The effect of cytosine-arabinoside on the multiplication of cytomegalovirus and on the formation of virus induced intracellular antigens. Acta virologica (in the press)
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-18-2-143
Loading
/content/journal/jgv/10.1099/0022-1317-18-2-143
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error